Pharmaceutical

Explore the intricacies of separation science within the pharmaceutical industry. Unveil techniques and technologies vital for isolating, purifying, and analyzing compounds, fostering advancements in drug development, quality control, and research. Discover the latest innovations driving precision and efficiency in pharmaceutical separation processes.

Illustration of tumor cells with molecular targets for mapping
News

Sapient Launches Tumor Protein Mapping Platform for Oncology Drug Development

PCR tubes held by a gloved hand in a lab setting
News

Bio-Rad Launches PTC Harmony Thermal Cyclers for PCR Workflows

Visual integration of digital quality management systems in lab settings
Articles

Digital Transformation in Pharmaceutical Quality: AI, Automation, and QMS Training

Checking procedures for hydrogen or nitrogen transition
Articles

Switching Carrier Gases in GC and GC–MS: What Labs Need to Know

A laboratory technician using a pipette to transfer liquid into test tubes.
Articles

Method Validation vs Verification vs Transfer Explained for GMP Labs

Detailed view of an inert GC column used in analytical chemistry
Articles

Why GC Column Inertness Still Shapes Difficult GC Analyses

Abstract visualization of data integrity and agentic AI in laboratories
Articles

Agentic AI in the Lab: Laying the Foundations for Real-World Use

Assorted colorful pharmaceutical pills and capsules on a white surface, representing the expanding pipeline of accessible therapeutics driven by Next-Generation Biosimilar Development.
Articles

Next-Generation Biosimilarity: Leveraging Advanced Analytical Techniques and PK Data to Meet New FDA Guidance

A scientist in a cleanroom suit, face mask, and gloves adjusts stainless steel bioprocessing equipment, illustrating process intensification in a sterile biomanufacturing environment.
Articles

Process Intensification in Biomanufacturing: Productivity Gains, Downstream Pressure, and the Reality of Trade-Offs

Scientist taking notes on bimiralisib oncology drug
News

Swiss Rockets and Lonza Advance Bimiralisib into Late-Stage Development